Menlo Advisors’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-5,889
Closed -$1.08M 42
2020
Q4
$1.08M Sell
5,889
-428
-7% -$70.4K 0.72% 29
2020
Q3
$950K Sell
6,317
-72
-1% -$11.3K 0.74% 28
2020
Q2
$938K Sell
6,389
-15,256
-70% -$2.52M 0.73% 30
2020
Q1
$3.26M Sell
21,645
-4,129
-16% -$801K 3.08% 14
2019
Q4
$5.41M Sell
25,774
-162
-0.6% -$31.8K 3.53% 12
2019
Q3
$4.87M Buy
25,936
+7
+0% +$1.37K 3.41% 14
2019
Q2
$5.18M Buy
25,929
+2,797
+12% +$596K 3.57% 9
2019
Q1
$4.84M Buy
23,132
+2,270
+11% +$461K 3.44% 11
2018
Q4
$3.98M Buy
+20,862
New +$4.06M 3.1% 17

Other funds holding MSGS

Menlo Advisors's MSGS Position: Q1 2021 in Review

Menlo Advisors sold out of Madison Square Garden (MSGS) in Q1 2021, closing a stake of 5,889 shares — an estimated $1.08M sold.

Menlo Advisors first reported a position in MSGS in Q4 2018 and held it in 9 quarters. The position peaked at $5.41M in Q4 2019. 303 funds tracked by Wall St. Rank hold MSGS as of Q1 2021.

  • Menlo Advisors reported no remaining Madison Square Garden position as of Q1 2021 after selling out during the quarter.
  • Menlo Advisors sold 5,889 Madison Square Garden shares in Q1 2021, an estimated $1.08M.
  • Menlo Advisors first reported a position in Madison Square Garden in Q4 2018 and held it in 9 quarters.
  • Menlo Advisors's Madison Square Garden position peaked at $5.41M in Q4 2019.
  • 303 funds tracked by Wall St. Rank held Madison Square Garden as of Q1 2021.

Based on Menlo Advisors's 13F filing for Q1 2021, filed 13 Apr 2021.